Cite

HARVARD Citation

    Danson, S. et al. (2020). Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716. Lung cancer. pp. 145-151. [Online]. 
  
Back to record